Magnetic_JJ
waves_NN
to_TO
treat_VB
depression_NN
?_.
The_DT
idea_NN
may_POMD
sound_VB
newfangled_JJ
,_,
but_CC
that_DEMP
's_VPRT [CONT]
exactly_RB
what_WP
psychiatrists_NN
around_PLACE
the_DT
world_NN
have_VPRT [PEAS]
turned_VBN
to_TO
''_''
repetitive_JJ
Transcranial_NN
Magnetic_JJ
Stimulation_NOMZ
-LRB-_-LRB-
rTMS_NN
-RRB-_-RRB-
,_,
as_IN
the_DT
technology_NN
is_VPRT [PASS]
called_VBN
,_,
in_PIN
their_TPP3
fight_NN
against_PIN
this_DEMO
mental_JJ
illness_NOMZ
,_,
which_WDT [SERE]
statistics_NN
say_VPRT [PUBV]
affects_VPRT
around_PLACE
5_CD
%_NN
of_PIN
the_DT
population_NOMZ
of_PIN
India_NN
._.
And_ANDC
they_TPP3
report_VPRT [PUBV]
encouraging_JJ
results_NN
._.
Dr_NN
Meena_NN
Kasargod_NN
,_,
consultant_NN
psychiatrist_NN
at_PIN
the_DT
Columbia_NN
Asia_NN
Referral_NN
Hospital_NN
,_,
Yeshwanthpur_NN
-LRB-_-LRB-
Bengaluru_NN
-RRB-_-RRB-
,_,
has_VPRT [PEAS]
been_VBN
using_VBG
rTMS_NN
for_PIN
the_DT
past_JJ
six_CD
years_NN
._.
``_``
Magnetic_JJ
impulses_NN
are_VPRT [PASS]
made_VBN
to_TO
penetrate_VB
4_CD
mm_NN
into_PIN
the_DT
brain_NN
to_TO
target_VB
the_DT
left_JJ
prefrontal_JJ
cortex_NN
,_,
which_WDT [SERE]
is_VPRT [PASS]
known_VBN [PRIV]
to_TO
function_VB
abnormally_RB
in_PIN
depression_NN
,_,
''_''
she_TPP3
explains_VPRT [PUBV]
._.
rTMS_NN
,_,
Kasargod_NN
says_VPRT [PUBV]
,_,
is_VPRT
``_``
thought_VBN [PRIV]
to_TO
work_VB
exactly_RB
like_IN
medicines_NN
,_,
causing_VBG [PRESP]
a_DT
redistribution_NOMZ
of_PIN
chemicals_NN
inside_PLACE
the_DT
brain_NN
._.
''_''
These_DEMP
are_VPRT
serotonin_NN
,_,
norepinephrine_NN
and_PHC
dopamine_NN
,_,
which_WDT [SERE]
regulate_VPRT
mood_NN
,_,
and_ANDC
are_VPRT [PASS]
imbalanced_VBN
during_PIN
depression_NN
._.
Patients_NN
are_VPRT [PASS]
given_VBN
20_CD
half-hour_JJ
sessions_NN
a_DT
month_NN
,_,
and_ANDC
report_NN
feeling_GER
80_CD
%_NN
better_JJ
and_CC
lead_VPRT
a_DT
better_JJ
quality_NOMZ
of_PIN
life_NN
._.
rTMS_NN
is_VPRT [BEMA]
among_PIN
a_DT
range_NN
of_PIN
fast_JJ
emerging_VBG
technologies_NN
,_,
called_VBN
`_``
neuromodulation_NOMZ
'_''
,_,
being_VBG [PASS]
used_VBN
to_TO
treat_VB
psychiatric_JJ
illnesses_NOMZ
in_PIN
hospitals_NN
such_JJ
as_IN
AIIMS_NN
,_,
NIMHANS_NN
,_,
and_ANDC
PGI-Chandigarh_NN
,_,
over_IN
the_DT
past_JJ
decade_NN
or_CC
so_RB
._.
Some_QUAN
of_PIN
these_DEMP
,_,
like_IN
rTMS_NN
,_,
are_VPRT [BEMA]
non-invasive_PRED
._.
Others_NN
like_IN
Deep_NN
Brain_NN
Stimulation_NOMZ
,_,
-LRB-_-LRB-
DBS_NN
-RRB-_-RRB-
require_VPRT [SUAV]
surgery_NN
._.
DBS_NN
,_,
involves_VPRT
inserting_VBG
an_DT
electrode_NN
,_,
or_CC
LED_NN
inside_PLACE
the_DT
brain_NN
,_,
which_WDT [SERE]
emits_VPRT
periodic_JJ
electrical_JJ
signals_NN
to_TO
stimulate_VB
affected_JJ
parts_NN
of_PIN
the_DT
brain_NN
._.
This_DEMP
is_VPRT [SPAU] [PASS]
widely_RB
used_VBN
in_PIN
the_DT
treatment_NOMZ
of_PIN
Parkinson_NN
's_POS
Disease_NN
and_CC
also_RB
Obsessive_NN
Compulsive_NN
Disorder_NN
-LRB-_-LRB-
OCD_NN
-RRB-_-RRB-
._.
According_VBG [PRESP]
to_PIN
Dr_NN
Anurag_NN
Gupta_NN
,_,
consultant_NN
neurosurgeon_NN
at_PIN
the_DT
Fortis_NN
Flt_NN
._.
Lt._NN
Rajan_NN
Dhall_NN
Hospital_NN
in_PIN
Vasant_NN
Kunj_NN
,_,
Delhi_NN
,_,
``_``
The_DT
brain_NN
's_POS
limbic_JJ
system_NN
controls_NN
behavior_NN
and_PHC
emotions_NOMZ
,_,
and_ANDC
any_QUAN
chemical_NN
disbalance_NN
,_,
or_CC
a_DT
tumor_NN
or_CC
stroke_NN
that_TSUB
affects_VPRT
the_DT
limbic_JJ
system_NN
can_POMD
cause_VB
psychological_JJ
disorders_NN
._.
When_RB
you_SPP2
target_VPRT
the_DT
limbic_JJ
system_NN
,_,
it_PIT
can_POMD
help_VB
to_TO
control_VB
OCD_NN
._.
''_''
At_PIN
Jaslok_NN
Hospital_NN
in_PIN
Mumbai_NN
,_,
Dr_NN
Paresh_NN
Doshi_NN
,_,
director_NN
of_PIN
the_DT
department_NOMZ
of_PIN
neurosurgery_NN
,_,
has_VPRT [SPAU] [PEAS]
even_RB
used_VBN
DBS_NN
to_TO
treat_VB
depression_NN
._.
``_``
We_FPP1
have_VPRT [PEAS]
done_VBN [PROD]
surgeries_NN
on_PIN
14_CD
patients_NN
of_PIN
OCD_NN
and_PHC
depression_NN
,_,
including_VBG [PRESP]
three_CD
from_PIN
Australia_NN
and_CC
two_CD
from_PIN
the_DT
US_FPP1
,_,
''_''
he_TPP3
says_VPRT [PUBV]
._.
The_DT
hospital_NN
will_PRMD [SPAU]
also_RB
shortly_TIME
launch_VB
rTMS_NN
and_PHC
Vegal_NN
Nerve_NN
Stimulation_NOMZ
-LRB-_-LRB-
VNS_NN
-RRB-_-RRB-
,_,
another_DT
emergent_NN
neuromodulation_NOMZ
technique_NN
,_,
which_WDT [SERE]
has_VPRT [PEAS]
proved_VBN [PRIV]
effective_JJ
in_PIN
the_DT
treatment_NOMZ
of_PIN
depression_NN
._.
In_PIN
VNS_NN
,_,
explains_VPRT [PUBV]
Doshi_NN
,_,
an_DT
electrode_NN
,_,
``_``
like_IN
a_DT
pacemaker_NN
''_''
,_,
is_VPRT [BYPA]
inserted_VBN
by_PIN
surgical_JJ
procedure_NN
near_PLACE
the_DT
collarbone_NN
to_TO
modulate_VB
serotonin_NN
levels_NN
._.
``_``
It_PIT
has_VPRT
a_DT
60_CD
%_NN
-70_CD
%_NN
success_NN
rate_NN
,_,
''_''
he_TPP3
says_VPRT [PUBV]
._.
rTMS_NN
,_,
on_CONJ
the_NULL
other_NULL
hand_NULL
,_,
has_VPRT
a_DT
40_CD
%_NN
-50_CD
%_NN
success_NN
rate_NN
and_CC
may_POMD
require_VB [SUAV]
repeated_VBN [PUBV]
sittings_GER
._.
Besides_PIN
depression_NN
,_,
rTMS_NN
has_VPRT [SPAU] [PEAS]
also_RB
been_VBN [PASS]
found_VBN [PRIV]
effective_JJ
in_PIN
treating_VBG
Anxiety_NN
Disorders_NN
,_,
Attention_NOMZ
Deficit_NN
Hyperactivity_NOMZ
Disorder_NN
-LRB-_-LRB-
ADHD_NN
-RRB-_-RRB-
,_,
Tourette_NN
Syndrome_NN
-LRB-_-LRB-
a_DT
disorder_NN
characterised_VBN [WZPAST]
by_PIN
tics_NN
,_,
or_CC
repetitive_JJ
,_,
involuntary_JJ
movement_NOMZ
-RRB-_-RRB-
,_,
and_ANDC
Anorexia_NN
Nervosa_NN
._.
While_OSUB
they_TPP3
do_VPRT
n't_XX0 [CONT]
obviate_VB
the_DT
need_NN
for_PIN
medicines_NN
,_,
rTMS_NN
causes_VPRT
them_TPP3
to_TO
be_VB
far_PLACE
more_EMPH
effective_JJ
,_,
leading_VBG [PRESP]
to_PIN
lower_JJ
dosages_NN
,_,
says_VPRT [PUBV]
Kasargod_NN
._.
Even_RB
surgical_JJ
procedures_NN
such_JJ
as_IN
DBS_NN
do_VPRT
not_XX0
damage_VB
the_DT
brain_NN
unlike_IN
earlier_TIME
surgeries_NN
,_,
which_WDT [SERE]
caused_VBD
lesions_NN
,_,
says_VPRT [PUBV]
Gupta_NN
._.
``_``
It_PIT
does_VPRT
not_XX0
`_``
cure_VB
'_''
,_,
but_CC
gives_VPRT
symptomatic_JJ
benefits_NN
and_CC
so_RB
helps_VPRT
quality_NOMZ
of_PIN
life_NN
to_TO
become_VB
better_RB
._.
In_PIN
that_DEMO
sense_NN
,_,
it_PIT
has_VPRT
the_DT
same_JJ
effect_NN
as_IN
medication_NOMZ
,_,
but_CC
without_PIN
the_DT
side_NN
effects_NN
._.
''_''
Agrees_VPRT [SUAV] [PUBV]
Dr_NN
Guruprasad_NN
Hosurkar_NN
,_,
neurologist_NN
at_PIN
Columbia_NN
Asia_NN
Hospital_NN
,_,
``_``
The_DT
complications_NOMZ
with_PIN
DBS_NN
are_VPRT
less_RB
._.
When_RB
it_PIT
is_VPRT [PASS]
switched_VBN
off_PIN [STPR]
,_,
the_DT
brain_NN
goes_VPRT
back_RB
to_TO
being_VBG
what_WP
it_PIT
was_VBD
._.
''_''
But_CC
there_EX
are_VPRT
some_QUAN
pitfalls_NN
,_,
the_DT
most_EMPH
important_JJ
being_VBG [BEMA]
the_DT
lack_NN
of_PIN
regulation_NOMZ
._.
There_EX
are_VPRT
high_JJ
costs_NN
,_,
for_PIN
one_CD
._.
While_OSUB
rTMS_NN
costs_NN
around_PLACE
Rs_NN
60,000_CD
for_PIN
the_DT
entire_JJ
treatment_NOMZ
,_,
DBS_NN
is_VPRT
far_PLACE
more_EMPH
expensive_JJ
at_PIN
around_PLACE
Rs_NN
10_CD
lakh_NN
for_PIN
the_DT
surgery_NN
._.
Two_CD
,_,
in_PIN
the_DT
US_FPP1
,_,
the_DT
FDA_NN
approved_VBD
rTMS_NN
only_DWNT
in_PIN
2008_CD
,_,
but_CC
only_DWNT
in_PIN
the_DT
treatment_NOMZ
of_PIN
depression_NN
._.
As_IN
for_PIN
DBS_NN
,_,
says_VPRT [PUBV]
Gupta_NN
,_,
it_PIT
has_VPRT [PEAS]
been_VBN [PASS]
certified_VBN [PUBV]
for_PIN
use_NN
by_PIN
the_DT
USFDA_NN
for_PIN
just_EMPH
three_CD
conditions_NOMZ
''_''
Parkinson_NN
's_POS
,_,
OCD_NN
and_PHC
Dystonia_NN
-LRB-_-LRB-
a_DT
movement_NOMZ
disorder_NN
-RRB-_-RRB-
._.
In_PIN
India_NN
,_,
the_DT
regulatory_JJ
mechanism_NN
for_PIN
any_QUAN
developing_VBG
technology_NN
such_JJ
as_IN
neuromodulation_NOMZ
is_VPRT [BEMA]
much_QUAN
more_EMPH
slack_NN
._.
According_VBG [PRESP]
to_PIN
Doshi_NN
,_,
the_DT
Mental_NN
Health_NN
Act_NN
,_,
2017_CD
allows_VPRT [SUAV]
psychiatric_JJ
surgery_NN
to_TO
be_VB [PASS]
performed_VBN
,_,
with_PIN
the_DT
provision_NN
that_TOBJ
it_PIT
should_NEMD
be_VB [BYPA]
overseen_VBN
by_PIN
an_DT
ethics_NN
committee_NN
or_CC
a_DT
hospital_NN
review_NN
board_NN
._.
